SHBG

There are 77 papers on SHBG in aging research: 15 trials and 40 observational studies in people, 2 in animals, 20 reviews. The newest story, Oct 8, 2026: “Fat-free mass links to metabolic health varied with deep belly fat”.

Biomarker

77 papers study it54 findings

6 new papers in 30 daysSee all 77 papers on SHBG

At a glance

Higher SHBG is linked with longer lifespan in women, but also with higher Alzheimer's disease risk in women and fracture risk in men and women in human observational studies. A cohort shows no clear link with vascular dementia in women. Human trials report SHBG increases with exercise and with tamoxifen in women.

54 findings in 38 papers from 1998 to 2026, 12 of them since May 2026

“in adherent subjects (>90%), LI plus ICR was significantly associated with higher SHBG compared with LI alone (p = 0.045).”
Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk womenEuropean journal of cancer (Oxford, England : 1990)2026doi:10.1016/j.ejca.2026.117784
  • Human trial15
  • Humans40
  • Animals2

Interventions

14

Tamoxifen

upin humans3+19%

3 studies
  1. Tamoxifen increases SHBG in humans (Women at high breast cancer risk; with or without intermittent caloric restriction).

    “LDT±ICR significantly increased SHBG and IGFBP-3 and decreased IGF-I”

    Human trialWomen at high breast cancer risk; with or without intermittent caloric restriction10 mg every other day6 monthsfemales

    Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women

    European journal of cancer (Oxford, England : 1990)

  2. Tamoxifen increases SHBG in humans (+19%).

    “Tamoxifen dose was associated with measurable endocrine changes after 6 months, most consistently increased SHBG levels, with additional associations observed for cortisol and hydroxyprogesterone.”

    Human trial6 monthsfemalesn = 1,025

    Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention

    Journal of the National Cancer Institute

  3. Tamoxifen increases SHBG in humans.

    “most consistently increased SHBG levels”

    Human trial1, 2.5, 5, 10, or 20 mg dailyplasma6 monthsfemalesn = 1,055

    Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention

    Journal of the National Cancer Institute

  4. Tamoxifen increases SHBG in women with breast cancer or at risk of developing breast cancer (WMD: 21.26 nmol/l, 95 % CI: 14.85, 27.68, p = 0.000).

    “SHBG levels (WMD: 21.26 nmol/l, 95 % CI: 14.85, 27.68, p = 0.000)”

    Reviewin women with breast cancer or at risk of developing breast cancer

    The effect of tamoxifen on estradiol, SHBG, IGF-1, and CRP in women with breast cancer or at risk of developing breast cancer: a meta-analysis of randomized controlled trials

    Experimental gerontology

More on Tamoxifen

GLP-1 receptor agonists

upin humans1no changein humans1

2 studies
  1. GLP-1 receptor agonists increase SHBG in humans (MD 7.00, 95%CI 1.71-12.30).

    “A significant increase was found regarding TT, SHBG, and FSH, MD 73.04, 95%CI: 16.91-129.17, MD 7.00, 95%CI: 1.71-12.30, and MD 0.46, 95%CI: 0.01-0.91 respectively.”

    Human trialmalesn = 237

    Glucagon-like receptor-1 agonists and impotence: A meta-analysis

    World journal of methodology

  2. GLP-1 receptor agonists showed no clear effect on SHBG in humans (pooled across four studies (one randomized controlled trial)) (MD 4.29 nmol/L (95% CI -1.87 to 10.46 nmol/L)).

    “no statistically significant differences were observed between the GLP-1RA and control groups for total testosterone levels (MD: 53.37 ng/dL, 95% CI: -32.6 to 139.34 ng/dL) or SHBG levels”

    Reviewpooled across four studies (one randomized controlled trial)malesn = 396

    SAT-147 The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Erectile Dysfunction and Testosterone Levels: A Systematic Review and Meta-Analysis

    ENDO 2025 abstract

More on GLP-1 receptor agonists

Physical activity

upin humans2

2 studies
  1. Physical activity increases SHBG in humans.

    “Following PA interventions, no changes in androstenedione, conflicting changes in dehydroepiandrosterone/dehydroepiandrosterone-sulfate, and increases in sex hormone-binding globulin concentrations were found.”

    Reviewfemales

    Examining the Role of Physical Activity Interventions in Modulating Androgens and Cardiovascular Health in Postmenopausal Women: A Narrative Review

    CJC open

  2. Physical activity increases SHBG in humans.

    “Estrogens, progesterone, and androgens mostly decreased, and SHBG increased, in response to physical activity.”

    Reviewfemales

    Linking Physical Activity to Breast Cancer via Sex Hormones, Part 1: The Effect of Physical Activity on Sex Steroid Hormones

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on Physical activity

Suppressing ketosis

downin humans1

1 study
  1. Suppressing ketosis decreases SHBG in humans (107.70 nmol/L (± 49.74, P1) to 72.53 nmol/L (± 35.43, P2)).

    “Following P2, SHBG significantly decreased from 107.70 nmol/L (± 49.74, P1) to 72.53 nmol/L (± 35.43, P2; p = 0.0060).”

    Human trialfemalesn = 10

    Ketosis suppression and ageing (KetoSAge): the effect of suppressing ketosis on SHBG and sex hormone profiles in healthy premenopausal women, and its implications for cancer risk and therapy

    Frontiers in nutrition

  2. Suppressing ketosis decreases SHBG in humans (0.67-fold decrease, p = 0.0015).

    “Suppression of ketosis resulted in a significant 0.67-fold decrease in SHBG levels (p = 0.0015).”

    Human trial21-daysfemalesn = 10

    Ketosis suppression and ageing (KetoSAge): the effect of suppressing ketosis on SHBG and sex hormone profiles in healthy premenopausal women, and its implications for cancer risk and therapy

    Frontiers in nutrition

More on Suppressing ketosis

Red wine

no changein humans1upin humans1

1 study
  1. Red wine showed no clear effect on SHBG in humans.

    “increases circulating SHBG in women but not in men.”

    Human trialhigh resveratrol content14 daysmalesn = 26

    Effect of Resveratrol Content in Red Wine on Circulating Sex Hormone-Binding Globulin: Lessons from a Pilot Clinical Trial

    Molecular nutrition & food research

  2. Red wine increases SHBG in humans.

    “red wine with high resveratrol content increases circulating SHBG in women but not in men.”

    Human trialhigh resveratrol content14 daysfemalesn = 26

    Effect of Resveratrol Content in Red Wine on Circulating Sex Hormone-Binding Globulin: Lessons from a Pilot Clinical Trial

    Molecular nutrition & food research

More on Red wine

Testosterone replacement therapy

upin humans1downin humans1

1 study
  1. Testosterone replacement therapy increases SHBG in humans (baseline SHBG <= 28.1 nmol/L and age <= 63 years (subgroup 1) in men with T2DM and TD) (c = 4.67, 95%CI 1.17-8.16, P = .010).

    “In men with both SHBG ≤ 28.1 nmol/L and age ≤ 63 years (subgroup 1), TRT was positively associated with ∆SHBG (c = 4.67, 95%CI 1.17-8.16, P = .010)”

    Human trialbaseline SHBG <= 28.1 nmol/L and age <= 63 years (subgroup 1) in men with T2DM and TDmales

    Testosterone replacement therapy: Pre-treatment sex hormone-binding globulin levels and age may identify clinical subgroups

    Andrology

  2. Testosterone replacement therapy decreases SHBG in humans (baseline SHBG > 28.1 nmol/L and age > 63.1 years (subgroup 4) in men with T2DM and TD) (c = -7.07, 95%CI -11.64 to -2.49, P = .003).

    “in those with SHBG > 28.1 nmol/L and age > 63.1 years (subgroup 4) the association was inverse (c = -7.07, 95%CI -11.64 to -2.49, P = .003).”

    Human trialbaseline SHBG > 28.1 nmol/L and age > 63.1 years (subgroup 4) in men with T2DM and TDmales

    Testosterone replacement therapy: Pre-treatment sex hormone-binding globulin levels and age may identify clinical subgroups

    Andrology

More on Testosterone replacement therapy

Weight loss

upin humans1

1 study
  1. Weight loss increases SHBG in humans (weight loss intervention).

    “and an increase in sex hormone binding globulin (SHBG).”

    Reviewweight loss intervention

    Adiposity and sex steroid hormones: evidence on direct measures and changes over time -- a systematic review and meta-analysis

    medRxivPreprint

More on Weight loss

Exercise

upin humans1

1 study
  1. Exercise increases SHBG in humans (polycystic ovary syndrome).

    “moderate-to-low intensity exercise specifically increased sex hormone-binding globulin”

    Human trialpolycystic ovary syndromemoderate-to-low intensityfemales

    The Effect of Exercise on Reproductive and Metabolic Outcomes in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

    The journal of obstetrics and gynaecology research

More on Exercise

Sleeve gastrectomy

upin humans1

1 study
  1. Sleeve gastrectomy increases SHBG in humans (to 64.0 (± 12.0) nmol/L).

    “Hormonal shifts included FSH rising to 9.0 (± 1.0) mIU/mL, LH to 9.0 (± 1.0) mIU/mL, SHBG to 64.0 (± 12.0) nmol/L, estradiol to 49.0 (± 4.0) pg/mL, free testosterone dropping to 9.0 (± 2.0) ng/dL, and HOMA-IR improving to 1.2 (± 0.3) (p < 0.001, Table 3).”

    Human trial12-monthfemalesn = 32

    Impact of Sleeve Gastrectomy on Obesity Indices, Reproductive Hormones, and Follicular Quality: A 12-Month Prospective Study

    Research SquarePreprint

More on Sleeve gastrectomy

Levocarnitine

no changein humans1

1 study
  1. Levocarnitine showed no clear effect on SHBG in overweight/obese women with PCOS; versus placebo (+11.5 ± 40.2 vs -3.2 ± 40.2; P = 0.2).

    “a non-significant change toward improvement in SHBG (+ 11.5 ± 40.2 vs. - 3.2 ± 40.2; P = 0.2)”

    Human trialin overweight/obese women with PCOS; versus placebo1000 mg/day12 weeksfemalesn = 62

    The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial

    European journal of nutrition

More on Levocarnitine

Aquatic exercise

upin humans1

1 study
  1. Aquatic exercise increases SHBG in humans (also seen with burdock root extract alone).

    “SHBG and estradiol levels were enhanced by both AE and BE”

    Human trialalso seen with burdock root extract alonefemales

    Exercise training and burdock root (Arctium lappa L.) extract independently improve abdominal obesity and sex hormones in elderly women with metabolic syndrome

    Scientific reports

More on Aquatic exercise

High-intensity interval training

upin humans1

1 study
  1. High-intensity interval training increases SHBG in humans (Cohen's d = 0.43).

    “SHBG increased following preconditioning (P = 0.016, Cohen’s d = 0.10 (42.6 ± 22.0 and 45.0 ± 23.9 nmol/L at A and B, respectively)) and again following HIIT (P = 0.003, Cohen’s d = 0.43 vs A (45.9 ± 24.6 nmol/L at phase C)).”

    Human trialmalesn = 22

    Exercise training improves free testosterone in lifelong sedentary aging men

    Endocrine connections

More on High-intensity interval training

Cholecalciferol

upin humans1

1 study
  1. Cholecalciferol increases SHBG in analyses limited to women with complete study pill counts (Vit D: 11.64 nmol/L (27.9%) versus P: 6.35 nmol/L (14.9%)).

    “In analyses limited to women with complete study pill counts, SHBG increased to a larger degree in the vitamin D arm compared to placebo (Vit D: 11.64 nmol/L (27.9%) versus P: 6.35 nmol/L (14.9%), p=0.03”

    Human trialin analyses limited to women with complete study pill counts12 months

    Effects of vitamin D supplementation during weight loss on sex hormones in postmenopausal women

    Menopause (New York, N.Y.)

More on Cholecalciferol

Dehydroepiandrosterone

downin humans1

1 study
  1. Dehydroepiandrosterone decreases SHBG in humans (Greater response in women than men) (Women: -40 +/- 8%, P = 0.002; men: -5 +/- 4%, P = 0.02; sex difference P < 0.02).

    “serum SHBG levels declined with a greater (P < 0.02) response in women (-40 +/- 8%; P = 0.002) than in men (-5 +/- 4%; P = 0.02).”

    Human trialGreater response in women than menserum100 mg daily6 months

    The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women

    Clinical endocrinology

More on Dehydroepiandrosterone

Effects

4

Breast cancer

no changein humans1

1 study
  1. SHBG was not clearly linked with breast cancer in humans (healthy premenopausal women) (SOR=0.92; 95% CI, 0.78-1.09).

    “the summary estimate in premenopausal women showed a non-significant 8% risk reduction (SOR=0.92; 95% CI, 0.78-1.09).”

    Humanshealthy premenopausal womenfemalesn = 35,167

    SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis

    Journal of the National Cancer Institute

More on Breast cancer

Lifespan

upin humans1

1 study
  1. SHBG is linked with longer lifespan in humans.

    “older age at first birth, later menarche, higher estradiol, and sex hormone-binding globulin (SHBG) increase longevity”

    Humansfemales

    Association of female reproductive traits with altered aging trajectories: Insights from genetic and observational analyses

    Cell reports. Medicine

Vascular dementia

no changein humans1HR 1.16

1 study
  1. SHBG was not clearly linked with vascular dementia in humans (HR: 1.16; 95% CI: 0.86-1.56).

    “this relationship was not significant for VAD (HR: 1.16; 95% CI: 0.86-1.56)”

    Humansmedian follow-up of 11.8 yearsfemalesn = 171,482

    Sex Hormone-Binding Globulin and Risk of Incident Dementia in Middle-Aged to Older Women: Results from the UK Biobank Cohort Study

    Neuroendocrinology

More on Vascular dementia

Bone mineral density

downin humans1

1 study
  1. SHBG is linked with lower bone mineral density in humans (adjusted for multiple covariables) (β = -0.029).

    “serum SHBG (β = -0.029), FSH (β = -0.065), LH (β = -0.049), E1 (β = 0.019), and cFT (β = 0.033) remained significantly associated with hip BMD”

    Humansadjusted for multiple covariableshipaverage of 6 years of follow-upmalesn = 1,705

    Progressive Temporal Change in Serum SHBG, But Not in Serum Testosterone or Estradiol, Is Associated With Bone Loss and Incident Fractures in Older Men: The Concord Health and Ageing in Men Project

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Associations

25

Bone fracture

upin humans2HR 1.54

2 studies
  1. SHBG is linked with a higher risk of bone fracture in humans (highest versus lowest SHBG quartile) (HR 1.54, 95% CI 1.16-2.04, p = 0.003).

    “highest SHBG quartile associated with a significantly greater fracture risk compared with the lowest quartile (hazard ratio 1.54, 95% confidence interval 1.16-2.04, p = 0.003)”

    Humanshighest versus lowest SHBG quartile3.9 yearsfemalesn = 4,871

    Concentration and genetic regulation of sex hormone binding globulin and fracture risk in older women

    Climacteric : the journal of the International Menopause Society

  2. SHBG is linked with a higher risk of bone fracture in humans (multivariable-adjusted models) (β = 0.060).

    “temporal increase in serum SHBG over time remained associated with any fracture (β = 0.060) and hip fracture (β = 0.041) incidence”

    Humansmultivariable-adjusted modelsaverage of 6 years of follow-upmalesn = 1,705

    Progressive Temporal Change in Serum SHBG, But Not in Serum Testosterone or Estradiol, Is Associated With Bone Loss and Incident Fractures in Older Men: The Concord Health and Ageing in Men Project

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

More on Bone fracture

GLP-1

upin humans1

1 study
  1. SHBG is associated with GLP-1 in humans (β = 0.0152).

    “Statistically significant associations were found between SHBG and IGF-1 (β = −0.1624, p = 0.0172), GLP-1 (β = 0.0152, p = 0.0295), free T3 (β = −22.4130, p = 0.0001), and GGT (β = −7.7060, p = 0.0024;;, ).”

    Human trialfemalesn = 10

    Ketosis suppression and ageing (KetoSAge): the effect of suppressing ketosis on SHBG and sex hormone profiles in healthy premenopausal women, and its implications for cancer risk and therapy

    Frontiers in nutrition

  2. SHBG is associated with GLP-1 in humans (p = 0.0295).

    “A significant positive association between SHBG and GLP-1 (p = 0.0295) was observed.”

    Human trialfemalesn = 10

    Ketosis suppression and ageing (KetoSAge): the effect of suppressing ketosis on SHBG and sex hormone profiles in healthy premenopausal women, and its implications for cancer risk and therapy

    Frontiers in nutrition

More on GLP-1

Insulin

downin humans1

1 study
  1. SHBG is associated with insulin in humans (β = −7.5030).

    “A significant inverse association was observed between insulin and SHBG [effect estimate (β) = −7.5030, p = 0.0010;; ].”

    Human trialfemalesn = 10

    Ketosis suppression and ageing (KetoSAge): the effect of suppressing ketosis on SHBG and sex hormone profiles in healthy premenopausal women, and its implications for cancer risk and therapy

    Frontiers in nutrition

  2. SHBG is associated with insulin in humans (p = 0.0010).

    “SHBG was significantly and inversely associated with insulin (p = 0.0010), insulin resistance score (HOMA-IR; p = 0.0012)”

    Human trialfemalesn = 10

    Ketosis suppression and ageing (KetoSAge): the effect of suppressing ketosis on SHBG and sex hormone profiles in healthy premenopausal women, and its implications for cancer risk and therapy

    Frontiers in nutrition

More on Insulin

Android fat mass

downin humans1

1 study
  1. Android fat mass is associated with SHBG in humans (all participants).

    “higher android fat mass was associated with lower levels of SHBG in the sample with all participants”

    Humansall participants4 yearsfemalesn = 298

    Sex hormone-binding globulin during menopausal transition– associations with hormone therapy use, android fat, physical activity and eating behaviour

    Women's health (London, England)

Menopausal transition

upin humans1

1 study
  1. Menopausal transition is associated with SHBG in humans (PRE-POST group using hormone therapy).

    “During the follow-up, SHBG increased in PRE-POST group ( p = 0.036) among hormone therapy (HT) users”

    HumansPRE-POST group using hormone therapy4 yearsfemales

    Sex hormone-binding globulin during menopausal transition– associations with hormone therapy use, android fat, physical activity and eating behaviour

    Women's health (London, England)

NT-proBNP

upin humans1

1 study
  1. SHBG is associated with NT-proBNP in humans (Baseline, adjusted for cardiovascular risk factors) (Adjusted β = 0.32, p < 0.001).

    “Baseline NT-proBNP as a marker of myocardial stress was independently and positively associated with both SHBG and androstenedione”

    HumansBaseline, adjusted for cardiovascular risk factorsn = 2,590

    Androgen metabolism and heart failure risk: sex-specific associations with NT-proBNP in a population-based cohort

    ESC Congress 2026 abstract

More on NT-proBNP

Serum lipids

mixedin humans1

1 study
  1. SHBG is associated with serum lipids in humans (conventional and HC3 inference) (35 lipids under conventional inference; 32 under HC3 inference).

    “Sex hormone-binding globulin (SHBG) was associated with 35 lipids under conventional inference and 32 under HC3 inference.”

    Humansconventional and HC3 inferencen = 175

    Associations of Serum Lipids With Clinical-Amyloid Groups, CSF Aβ42, and SHBG in ADNI-1

    American journal of Alzheimer's disease and other dementias

More on Serum lipids

Intermittent caloric restriction

upin humans1

1 study
  1. Intermittent caloric restriction is associated with SHBG in humans.

    “in adherent subjects (>90%), LI plus ICR was significantly associated with higher SHBG compared with LI alone (p = 0.045).”

    Human trialAlongside lifestyle intervention versus lifestyle intervention alone; adherent subjects (>90%)6 monthsfemales

    Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women

    European journal of cancer (Oxford, England : 1990)

More on Intermittent caloric restriction

Breast cancer

downin humans1HR 0.6

1 study
  1. SHBG is linked with a lower risk of breast cancer in humans (high-risk premenopausal women enrolled in two low-dose tamoxifen trials) (HR = 0.60; 95% CI, 0.38-0.96; p = 0.03).

    “SHBG levels above the lowest tertile were associated with a 40% lower hazard of subsequent breast cancer events (HR = 0.60; 95% CI, 0.38-0.96; p = 0.03).”

    Humanshigh-risk premenopausal women enrolled in two low-dose tamoxifen trialsfemales

    SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis

    Journal of the National Cancer Institute

More on Breast cancer

Bone loss

upin humans1

1 study
  1. SHBG predicts bone loss in humans (discriminating between women with normal or low BMD) (sensitivity 86%, specificity 75%, precision 92%, overall performance 89.32%).

    “A random forest classifier demonstrated that SHBG and APOA1 are the most effective biomarkers for discriminating between women with normal or low BMD”

    Humansdiscriminating between women with normal or low BMDserumfemalesn = 456

    SHBG and APOA1 as serum biomarkers for low bone mineral density in Mexican postmenopausal women: a random forest-based analysis

    Frontiers in endocrinology

All 25

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human trials report increased SHBG with tamoxifen and with moderate-to-low-intensity exercise for polycystic ovary syndrome. Human studies associate SHBG with lower breast cancer risk in high-risk premenopausal women, but not healthy premenopausal women, and report that it predicts bone loss in women. A preprint review describes increased SHBG after weight loss.

  2. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 1Mar 2026: 0Apr 2026: 2May 2026: 2Jun 2026: 1Jul 2026: 2Aug 2026: 2Sep 2026: 5Oct 2026: 7Nov 2026: 328 papers in 12 months
The Journal of Clinical Endocrinology and Metabolism

Fat-free mass links to metabolic health varied with deep belly fat

A cross-sectional analysis of 59,269 UK Biobank participants found different metabolic associations depending on how fat-free mass was measured and fat around organs.A cross-sectional analysis of 59,269 UK Biobank participants found different metabolic associations depending on how fat-free mass was measured and fat around organs.

Cross-sectional study of 59,269 peopleMetabolic syndrome

See all 77 papers on SHBG